1. Post-hoc analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis. Issue 5 (3rd July 2019) Authors: Palumbo, Joseph M.; Hubble, Jean; Apple, Stephen; Takei, Koji; Tsuda, Kikumi; Liu, Shawn; Zhang, Jeffrey; Agnese, Wendy Journal: Amyotrophic lateral sclerosis and frontotemporal degeneration Issue: Volume 20:Issue 5/6(2019) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19). Issue 2 (11th November 2019) Authors: Shefner, Jeremy; Heiman‐Patterson, Terry; Pioro, Erik P.; Wiedau‐Pazos, Martina; Liu, Shawn; Zhang, Jeffrey; Agnese, Wendy; Apple, Stephen Journal: Muscle & nerve Issue: Volume 61:Issue 2(2020) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design. Issue 4 (August 2021) Authors: Berry, James; Brooks, Benjamin; Genge, Angela; Heiman-Patterson, Terry; Appel, Stanley; Benatar, Michael; Bowser, Robert; Cudkowicz, Merit; Gooch, Clifton; Shefner, Jeremy; Westra, Jurjen; Agnese, Wendy; Merrill, Charlotte; Nelson, Sally; Apple, Stephen Journal: Neurology Issue: Volume 11:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Engaging ALS patients and caregivers (the ALS research ambassadors) to help design the REFINE-ALS biomarker study. Issue 1 (2nd January 2021) Authors: Berry, James D.; Bedlack, Richard; Mathews, Debra; Agnese, Wendy; Apple, Stephen Journal: Amyotrophic lateral sclerosis and frontotemporal degeneration Issue: Volume 22:Issue 1/2(2021) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS‐R item scores in pivotal study MCI186‐19. Issue 2 (10th December 2021) Authors: Brooks, Benjamin Rix; Pioro, Erik P.; Katz, Jonathan; Takahashi, Fumihiro; Takei, Koji; Zhang, Jeffrey; Apple, Stephen Journal: Muscle & nerve Issue: Volume 65:Issue 2(2022) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evidence for generalizability of edaravone efficacy using a novel machine learning risk-based subgroup analysis tool. Issue 1 (2nd January 2022) Authors: Brooks, Benjamin Rix; Pioro, Erik P.; Beaulieu, Danielle; Taylor, Albert A.; Schactman, Mark; Keymer, Mike; Agnese, Wendy; Perdrizet, Johnna; Apple, Stephen; Ennist, David L. Journal: Amyotrophic lateral sclerosis and frontotemporal degeneration Issue: Volume 23:Issue 1/2(2022) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19. Issue 2 (27th October 2020) Authors: Al-Chalabi, Ammar; Chiò, Adriano; Merrill, Charlotte; Oster, Gerry; Bornheimer, Rebecca; Agnese, Wendy; Apple, Stephen Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 92:Issue 2(2021) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Characterisation of Au surface properties relevant for UV photoemission-based charge control for space inertial sensors. (9th September 2020) Authors: Olatunde, Taiwo; Apple, Stephen; Inchauspé, Henri; Parry, Samantha; Letson, Benjamin; Wass, Peter J; Mueller, Guido; Conklin, John W Journal: Classical and quantum gravity Issue: Volume 37:Number 19(2020:Oct.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetics, Bioavailability, and Swallowing Safety With Riluzole Oral Film. Issue 1 (27th September 2022) Authors: Wymer, James; Apple, Stephen; Harrison, Antoinette; Hill, Bryan Alan Journal: Clinical pharmacology in drug development Issue: Volume 12:Issue 1(2023) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment. Issue 2 (28th December 2022) Authors: Genge, Angela; Pattee, Gary L.; Sobue, Gen; Aoki, Masashi; Yoshino, Hiide; Couratier, Philippe; Lunetta, Christian; Petri, Susanne; Selness, Daniel; Bidani, Sachin; Hirai, Manabu; Sakata, Takeshi; Salah, Alejandro; Apple, Stephen; Wamil, Art; Kalin, Alexander; Jackson, Carlayne E. Journal: Muscle & nerve Issue: Volume 67:Issue 2(2023) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗